202. Smith-Magenis syndrome Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 9 /  Drugs : 10 - (DrugBank : 5) / Drug target genes : 4 - Drug target pathways : 7

Smith-Magenis syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
IDDiseases (Sorted by score)Score
202Smith-Magenis syndrome-
37Generalised pustular psoriasis2.362
49Systemic lupus erythematosus2.270
97Ulcerative colitis2.266
46Malignant rheumatoid arthritis2.262
6Parkinson disease2.262
13Multiple sclerosis/Neuromyelitis optica2.258
149Hemiconvulsion hemiplegia epilepsy syndrome1.118
145West syndrome1.074
90Retinitis pigmentosa1.041
144Lennox-Gastaut syndrome1.041
8Huntington disease1.024